Pharming updates on ongoing call of first tranche of €10 million equity working capital facility and study 1310
03:00 EDT 13 Aug 2012 | Thomson Reuters
This article has expired, however you can still
download the PDF.
Preview:
Leiden, The Netherlands, August 13, 2012. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) today announces that the investors have increased the first call under the facility by 13,000,000 shares f...
Other Sources for this Article
More From BioPortfolio on "Pharming updates on ongoing call of first tranche of €10 million equity working capital facility and study 1310"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
